WealthPLAN Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-250	Closed	-$11.9K	–	192
2017 Q1	$11.9K	Buy	+250	New	+$11.9K	0.04%	244
2016 Q3	$17.1K	Sell	250 -250	-50%	-$17.1K	0.01%	510
2016 Q2	$13.9K	Buy	+500	New	+$13.9K	﹤0.01%	1594
2015 Q4	$23.6K	Buy	+750	New	+$23.6K	﹤0.01%	863